SOLV Earnings Date: Nov 5, 2026 (Estimated) — Solventum Corporation
NYSE · Healthcare · Medical Instruments & Supplies
Updated
When is SOLV's next earnings date?
Solventum Corporation (SOLV) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.34 on revenue of $1.93B.
How did SOLV do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Solventum Corporation posted EPS of $2.55 versus the $1.90 estimate, a beat of 34.2%. Revenue was $2.21B against a $2.15B estimate. The stock's 1-day post-earnings move was -5.2%.
How much does SOLV stock move after earnings?
SOLV beat EPS estimates in 7 of its last 7 reported quarters. Over the last 7 reports the stock moved an average of 4.2% (up or down) in the day after earnings.
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 1.90 | 2.55 | +34.21% | $2.21B | ✅ Beat | -5.16% | -2.49% | +5.68% |
| 2026-05-05 | Q1 2026 | 1.35 | 1.48 | +9.63% | $2.01B | ✅ Beat | +2.82% | +8.78% | +19.38% |
| 2026-02-26 | Q4 2025 | 1.50 | 1.57 | +4.67% | $2.00B | ✅ Beat | -3.56% | -8.01% | -18.43% |
| 2025-11-06 | Q3 2025 | 1.43 | 1.50 | +4.90% | $2.10B | ✅ Beat | +7.91% | +13.49% | +24.62% |
| 2025-08-07 | Q2 2025 | 1.45 | 1.69 | +16.55% | $2.16B | ✅ Beat | +2.00% | +1.74% | +3.68% |
| 2025-02-27 | Q4 2024 | 1.32 | 1.41 | +6.82% | $2.07B | ✅ Beat | -4.42% | -9.23% | -10.41% |
| 2024-11-07 | Q3 2024 | 1.39 | 1.64 | +17.99% | $2.08B | ✅ Beat | -3.52% | -9.55% | -5.91% |
| 2022-12-30 | — | 1.78 | — | $2.00B | — | — | — | — |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $2.12B total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| MedSurg | 64.7% | $1.37B | — | — | — | — | — |
| Dental Solutions | 18.7% | $396.0M | — | — | — | — | — |
| Health Information Systems | 16.7% | $354.0M | — | — | — | — | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.